Antacids Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
Market Report I 2023-09-03 I 255 Pages I Infinium Global Research and Consulting Solutions
The report on the global antacids market provides qualitative and quantitative analysis for the period from 2021-2030. The global antacids market was valued at USD 5.07 billion in 2022 and is expected to reach USD 7.38 billion in 2030, with a CAGR of more than 4.11% during the forecast period 2023-2030. The study on antacids market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
Antacids are over-the-counter medications that individuals can obtain without a prescription. They consist of a blend of different compounds, with calcium, magnesium, and aluminum salts serving as the active components. The primary mode of action for antacids involves neutralizing the stomach acid and inhibiting pepsin, an enzyme responsible for protein digestion. Each of these cationic salts possesses unique pharmacological properties that dictate their specific clinical applications. The increasing geriatric population around the world is the major driving factor responsible for the growth of the antacids market. According to data from World Population Prospects, the number of people aged 65 and older is projected to increase from 10% in 2022 to 16% in 2050. According to the 2019 World Population Prospects, by 2050, one in 6 people in the world will be over age 65. Additionally, the intake of medication for other medical conditions, which are associated with acid reflux and excess acid production also accounts for significant demand for antacids among this population.
Antacid tablets serve as widely used pharmaceutical products intended to alleviate symptoms associated with excessive stomach acidity and indigestion. These tablets are conveniently available without a prescription, making them easily attainable for consumers seeking prompt relief from common gastrointestinal discomfort. In addition, the primary purpose of antacid tablets is to counteract surplus stomach acid. They accomplish this by employing a blend of active ingredients, typically composed of various mineral salts like calcium, magnesium, and aluminum. These minerals function by interacting with the acidic substances present in the stomach, effectively neutralizing the acid and mitigating its potentially harmful effects on the stomach lining. Consequently, antacids are effective in relieving common symptoms such as heartburn, acid reflux, and stomach upset.
North America accounted for the largest share in the AI in the logistics market, in terms of region. The dominance of the U.S. in the field of AI is majorly attributed to the growth of AI in the logistics market in the North America region. High investment in AI by the government and private firms is supporting the market growth in North America. Moreover, North America region includes countries such as the U.S., and Canada has a large number of manufacturing facilities. Due to this, the demand for logistics is high in this region, as the manufacturing sector is a major end-user of logistics. The logistics suppliers use AI to match the growing demand from the manufacturing sector, in turn, augmenting the growth of Antacids in the North America region.
Report Findings
1) Drivers
- The rising prevalence of digestive disorders is driving the growth of the market.
- The changing dietary habits are contributing to the growth of the market.
2) Restraints
- The side effects associated with the consumption of antacids can hamper the growth of the market.
3) Opportunities
- Innovative product development may provide lucrative opportunities for the growth of the market.
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global antacids market is segmented on the basis of drug class, formulation, and distribution channel.
The Global Antacids Market by Drug Class
- Proton Pump Inhibitor
- H2 Antagonist
- Acid Neutralizers
The Global Antacids Market by Formulation
- Tablet
- Liquid
- Powder
The Global Antacids Market by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Company Profiles
The companies covered in the report include
- GSK plc.
- Bayer AG
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Procter & Gamble
- Acme United Corporation
- Allegiant Health
- Dr. Reddy's Laboratories Ltd.
- Reckitt Benckiser Group PLC
- WellSpring Pharmaceutical Corporation
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the antacids market.
2. Complete coverage of all the segments in the antacids market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global antacids market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Antacids Market Highlights
2.2. Antacids Market Projection
2.3. Antacids Market Regional Highlights
Chapter 3. Global Antacids Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drug Class
3.4.2. IGR-Growth Matrix Analysis by Formulation
3.4.3. IGR-Growth Matrix Analysis by Distribution Channel
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Antacids Market
Chapter 4. Antacids Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Antacids Market
5.2. Companies Profiles
5.2.1. GSK plc.
5.2.2. Bayer AG
5.2.3. Pfizer Inc.
5.2.4. Johnson & Johnson Services, Inc.
5.2.5. Procter & Gamble
5.2.6. Acme United Corporation
5.2.7. Allegiant Health
5.2.8. Dr. Reddy's Laboratories Ltd.
5.2.9. Reckitt Benckiser Group PLC
5.2.10. WellSpring Pharmaceutical Corporation
Chapter 6. Global Antacids Market by Drug Class
6.1. Proton Pump Inhibitor
6.2. H2 Antagonist
6.3. Acid Neutralizers
Chapter 7. Global Antacids Market by Formulation
7.1. Tablet
7.2. Liquid
7.3. Powder
Chapter 8. Global Antacids Market by Distribution Channel
8.1. Hospital Pharmacy
8.2. Retail Pharmacy
8.3. Online Pharmacy
Chapter 9. Global Antacids Market by Region 2023-2030
9.1. North America
9.1.1. North America Antacids Market by Drug Class
9.1.2. North America Antacids Market by Formulation
9.1.3. North America Antacids Market by Distribution Channel
9.1.4. North America Antacids Market by Country
9.1.4.1. The U.S. Antacids Market
9.1.4.1.1. The U.S. Antacids Market by Drug Class
9.1.4.1.2. The U.S. Antacids Market by Formulation
9.1.4.1.3. The U.S. Antacids Market by Distribution Channel
9.1.4.2. Canada Antacids Market
9.1.4.2.1. Canada Antacids Market by Drug Class
9.1.4.2.2. Canada Antacids Market by Formulation
9.1.4.2.3. Canada Antacids Market by Distribution Channel
9.1.4.3. Mexico Antacids Market
9.1.4.3.1. Mexico Antacids Market by Drug Class
9.1.4.3.2. Mexico Antacids Market by Formulation
9.1.4.3.3. Mexico Antacids Market by Distribution Channel
9.2. Europe
9.2.1. Europe Antacids Market by Drug Class
9.2.2. Europe Antacids Market by Formulation
9.2.3. Europe Antacids Market by Distribution Channel
9.2.4. Europe Antacids Market by Country
9.2.4.1. Germany Antacids Market
9.2.4.1.1. Germany Antacids Market by Drug Class
9.2.4.1.2. Germany Antacids Market by Formulation
9.2.4.1.3. Germany Antacids Market by Distribution Channel
9.2.4.2. United Kingdom Antacids Market
9.2.4.2.1. United Kingdom Antacids Market by Drug Class
9.2.4.2.2. United Kingdom Antacids Market by Formulation
9.2.4.2.3. United Kingdom Antacids Market by Distribution Channel
9.2.4.3. France Antacids Market
9.2.4.3.1. France Antacids Market by Drug Class
9.2.4.3.2. France Antacids Market by Formulation
9.2.4.3.3. France Antacids Market by Distribution Channel
9.2.4.4. Italy Antacids Market
9.2.4.4.1. Italy Antacids Market by Drug Class
9.2.4.4.2. Italy Antacids Market by Formulation
9.2.4.4.3. Italy Antacids Market by Distribution Channel
9.2.4.5. Rest of Europe Antacids Market
9.2.4.5.1. Rest of Europe Antacids Market by Drug Class
9.2.4.5.2. Rest of Europe Antacids Market by Formulation
9.2.4.5.3. Rest of Europe Antacids Market by Distribution Channel
9.3. Asia Pacific
9.3.1. Asia Pacific Antacids Market by Drug Class
9.3.2. Asia Pacific Antacids Market by Formulation
9.3.3. Asia Pacific Antacids Market by Distribution Channel
9.3.4. Asia Pacific Antacids Market by Country
9.3.4.1. China Antacids Market
9.3.4.1.1. China Antacids Market by Drug Class
9.3.4.1.2. China Antacids Market by Formulation
9.3.4.1.3. China Antacids Market by Distribution Channel
9.3.4.2. Japan Antacids Market
9.3.4.2.1. Japan Antacids Market by Drug Class
9.3.4.2.2. Japan Antacids Market by Formulation
9.3.4.2.3. Japan Antacids Market by Distribution Channel
9.3.4.3. India Antacids Market
9.3.4.3.1. India Antacids Market by Drug Class
9.3.4.3.2. India Antacids Market by Formulation
9.3.4.3.3. India Antacids Market by Distribution Channel
9.3.4.4. South Korea Antacids Market
9.3.4.4.1. South Korea Antacids Market by Drug Class
9.3.4.4.2. South Korea Antacids Market by Formulation
9.3.4.4.3. South Korea Antacids Market by Distribution Channel
9.3.4.5. Australia Antacids Market
9.3.4.5.1. Australia Antacids Market by Drug Class
9.3.4.5.2. Australia Antacids Market by Formulation
9.3.4.5.3. Australia Antacids Market by Distribution Channel
9.3.4.6. Rest of Asia-Pacific Antacids Market
9.3.4.6.1. Rest of Asia-Pacific Antacids Market by Drug Class
9.3.4.6.2. Rest of Asia-Pacific Antacids Market by Formulation
9.3.4.6.3. Rest of Asia-Pacific Antacids Market by Distribution Channel
9.4. RoW
9.4.1. RoW Antacids Market by Drug Class
9.4.2. RoW Antacids Market by Formulation
9.4.3. RoW Antacids Market by Distribution Channel
9.4.4. RoW Antacids Market by Sub-region
9.4.4.1. Latin America Antacids Market
9.4.4.1.1. Latin America Antacids Market by Drug Class
9.4.4.1.2. Latin America Antacids Market by Formulation
9.4.4.1.3. Latin America Antacids Market by Distribution Channel
9.4.4.2. Middle East Antacids Market
9.4.4.2.1. Middle East Antacids Market by Drug Class
9.4.4.2.2. Middle East Antacids Market by Formulation
9.4.4.2.3. Middle East Antacids Market by Distribution Channel
9.4.4.3. Africa Antacids Market
9.4.4.3.1. Africa Antacids Market by Drug Class
9.4.4.3.2. Africa Antacids Market by Formulation
9.4.4.3.3. Africa Antacids Market by Distribution Channel
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.